BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 29331753)

  • 1. An iridium (III) complex as potent anticancer agent induces apoptosis and autophagy in B16 cells through inhibition of the AKT/mTOR pathway.
    Tang B; Wan D; Wang YJ; Yi QY; Guo BH; Liu YJ
    Eur J Med Chem; 2018 Feb; 145():302-314. PubMed ID: 29331753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The induction of apoptosis in SGC-7901 cells through the ROS-mediated mitochondrial dysfunction pathway by a Ir(III) complex.
    Zhang C; Lai SH; Zeng CC; Tang B; Wan D; Xing DG; Liu YJ
    J Biol Inorg Chem; 2016 Dec; 21(8):1047-1060. PubMed ID: 27796592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer and antibacterial activity in vitro evaluation of iridium(III) polypyridyl complexes.
    Yi QY; Zhang WY; He M; Du F; Wang XZ; Wang YJ; Gu YY; Bai L; Liu YJ
    J Biol Inorg Chem; 2019 Mar; 24(2):151-169. PubMed ID: 30564887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of anticancer effect in vitro and in vivo of iridium(III) complexes on gastric carcinoma SGC-7901 cells.
    Zhang WY; Wang YJ; Du F; He M; Gu YY; Bai L; Yang LL; Liu YJ
    Eur J Med Chem; 2019 Sep; 178():401-416. PubMed ID: 31202128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, characterization and anticancer activity in vitro and in vivo evaluation of an iridium (III) polypyridyl complex.
    Yi QY; Wan D; Tang B; Wang YJ; Zhang WY; Du F; He M; Liu YJ
    Eur J Med Chem; 2018 Feb; 145():338-349. PubMed ID: 29331805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photoinduced anticancer activity studies of iridium(III) complexes targeting mitochondria and tubules.
    Zhang WY; Yi QY; Wang YJ; Du F; He M; Tang B; Wan D; Liu YJ; Huang HL
    Eur J Med Chem; 2018 May; 151():568-584. PubMed ID: 29656200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iridium(III)-BBIP complexes induce apoptosis via PI3K/AKT/mTOR pathway and inhibit A549 lung tumor growth in vivo.
    Zhou Y; Bai L; Tian L; Yang L; Zhang H; Zhang Y; Hao J; Gu Y; Liu Y
    J Inorg Biochem; 2021 Oct; 223():111550. PubMed ID: 34311319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes-loaded liposomes as drug delivery system.
    Zhang WY; Du F; He M; Bai L; Gu YY; Yang LL; Liu YJ
    Eur J Med Chem; 2019 Sep; 178():390-400. PubMed ID: 31202127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria.
    Zhang H; Tian L; Xiao R; Zhou Y; Zhang Y; Hao J; Liu Y; Wang J
    Bioorg Chem; 2021 Oct; 115():105290. PubMed ID: 34426145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing anticancer effect in vitro and vivo of liposome-encapsulated iridium(III) complexes on BEL-7402 cells.
    Zhang Y; Fei W; Zhang H; Zhou Y; Tian L; Hao J; Yuan Y; Li W; Liu Y
    J Inorg Biochem; 2021 Dec; 225():111622. PubMed ID: 34624670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of anticancer effects in vitro of new iridium(III) complexes targeting the mitochondria.
    Hao J; Zhang H; Tian L; Yang L; Zhou Y; Zhang Y; Liu Y; Xing D
    J Inorg Biochem; 2021 Aug; 221():111465. PubMed ID: 33989986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents.
    Li J; Tian Z; Xu Z; Zhang S; Feng Y; Zhang L; Liu Z
    Dalton Trans; 2018 Nov; 47(44):15772-15782. PubMed ID: 30357192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
    Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
    Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iridium(III) complexes inhibit the proliferation and migration of BEL-7402 cells through the PI3K/AKT/mTOR signaling pathway.
    Chen J; Liu H; Chen Y; Hu H; Huang C; Wang Y; Liang L; Liu Y
    J Inorg Biochem; 2023 Apr; 241():112145. PubMed ID: 36709684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity studies of iridium (III) polypyridine complexes-loaded liposomes against gastric tumor cell in vitro.
    Xie FL; Huang ZT; Bai L; Zhu JW; Xu HH; Long QQ; Guo QF; Wu Y; Liu SH
    J Inorg Biochem; 2021 Dec; 225():111603. PubMed ID: 34564032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, characterization and anticancer activity studies of ruthenium(II) polypyridyl complexes on A549 cells.
    Zeng CC; Jiang GB; Lai SH; Zhang C; Yin H; Tang B; Wan D; Liu YJ
    J Photochem Photobiol B; 2016 Aug; 161():295-303. PubMed ID: 27288660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of anticancer activity in vivo and in vitro behaviors of liposomes encapsulated iridium(III) complex.
    Gu Y; Wen H; Zhang Y; Bai L; Zhou Y; Zhang H; Tian L; Hao J; Liu Y
    J Biol Inorg Chem; 2021 Feb; 26(1):109-122. PubMed ID: 33475857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomes encapsulated iridium(III) polypyridyl complexes enhance anticancer activity in vitro and in vivo.
    Bai L; Fei WD; Gu YY; He M; Du F; Zhang WY; Yang LL; Liu YJ
    J Inorg Biochem; 2020 Apr; 205():111014. PubMed ID: 32044395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis in SGC-7901 cells by iridium(III) complexes via endoplasmic reticulum stress-mitochondrial dysfunction pathway.
    Wang J; Liu H; Wu X; Shi C; Li W; Yuan Y; Liu Y; Xing D
    J Biol Inorg Chem; 2022 Aug; 27(4-5):455-469. PubMed ID: 35817878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iridium(III) complexes entrapped in liposomes trigger mitochondria-mediated apoptosis and GSDME-mediated pyroptosis.
    Zhang H; Liao X; Wu X; Shi C; Zhang Y; Yuan Y; Li W; Wang J; Liu Y
    J Inorg Biochem; 2022 Mar; 228():111706. PubMed ID: 35033830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.